Founded with the mission to enhance care quality through advanced airborne pathogen control technology, Novaerus focuses on improving business outcomes and care standards in skilled nursing and assisted living facilities. Their core products include the Defend 400 and other air cleaning technologies under the WellAir brand, featuring patented NanoStrike™ technology designed to inactivate airborne microorganisms. Novaerus emphasizes a preventative approach to infection control, complementing traditional hygiene protocols.
Notable figures affiliated with Novaerus include experts in healthcare and technology sectors who contribute to its innovative solutions. The company has attracted significant investment from entities focused on healthcare innovation. Key achievements include the successful deployment of their technology in various healthcare settings, significantly reducing airborne pathogens and improving indoor air quality. Novaerus's impact is evident in its contribution to safer, cleaner environments, particularly in vulnerable care facilities.
